Prohibits health insurance providers from requiring preauthorization for in- network mental health or substance use disorder services.
Summary
S0054 would amend Rhode Island’s insurance parity law for mental health and substance use disorder treatment. The bill requires group and individual health insurance plans to cover behavioral health treatment on the same terms and conditions as coverage for other illnesses, without annual or lifetime dollar limits, and with financial requirements and treatment limits no more restrictive than those applied to comparable medical/surgical care. It also specifies coverage classifications for inpatient, outpatient, emergency care, and prescription drugs, and includes medication-assisted treatment such as methadone, buprenorphine, and naltrexone within the appropriate benefit category.
The bill goes further by directing payors to use American Society of Addiction Medicine criteria when setting levels of care, requiring coverage for evidence-based non-opioid pain treatment such as chiropractic care and osteopathic manipulative treatment when medically necessary, and aligning cost-sharing for behavioral health counseling and medication maintenance visits with primary care office visits. Its most significant change is a prohibition on prior authorization for in-network mental health and substance use disorder services, with enforcement authority given to the Office of the Health Insurance Commissioner, including rulemaking and fines for violations.
Impact
If enacted, the bill would strengthen Rhode Island’s insurance coverage requirements for mental health and substance use disorder services by limiting utilization management and expanding parity protections under chapter 27-38.2. It would affect group health plans, individual and group insurers, and the Office of the Health Insurance Commissioner, while also influencing provider reimbursement and patient access to behavioral health, addiction treatment, and related non-opioid pain services. The bill would likely reduce administrative barriers for in-network care and could increase insurer compliance obligations and oversight activity.
Sentiment
The bill’s stated purpose and findings reflect strong support for expanding access to timely, medically necessary behavioral health and addiction treatment. The legislative findings emphasize low treatment rates for mental illness and substance use disorders and cite prior action by Blue Cross Blue Shield of Rhode Island as a model for the rest of the market. No committee votes or transcripts are provided, so there is no recorded opposition or amendment debate in the available materials; based on the text, the bill is framed as a parity and access measure with a generally pro-patient, pro-treatment orientation.
Contention
The main point of potential contention is the ban on prior authorization for in-network mental health and substance use disorder services, which limits insurer utilization review and may raise concerns about cost control, medical management, and administrative flexibility. Insurers may also scrutinize the bill’s requirement to use ASAM criteria, the inclusion of medication-assisted treatment and non-opioid pain therapies, and the directive that behavioral health cost sharing match primary care office visits. The Office of Health Insurance Commissioner would be responsible for enforcement, including fines, which could also be a point of concern for regulated entities.